Shmuel Yaccoby
Myeloma Institute for Research and Therapy
University of Arkansas for Medical Sciences
Little Rock
AR 72205
USA
Name/email consistency: high
- Osteoblastogenesis and tumor growth in myeloma. Yaccoby, S. Leuk. Lymphoma (2010)
- Atacicept (TACI-Ig) inhibits growth of TACI(high) primary myeloma cells in SCID-hu mice and in coculture with osteoclasts. Yaccoby, S., Pennisi, A., Li, X., Dillon, S.R., Zhan, F., Barlogie, B., Shaughnessy, J.D. Leukemia (2008)
- Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo. Yaccoby, S., Ling, W., Zhan, F., Walker, R., Barlogie, B., Shaughnessy, J.D. Blood (2007)
- Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse model. Yaccoby, S., Wezeman, M.J., Zangari, M., Walker, R., Cottler-Fox, M., Gaddy, D., Ling, W., Saha, R., Barlogie, B., Tricot, G., Epstein, J. Haematologica (2006)
- The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotype. Yaccoby, S. Clin. Cancer Res. (2005)
- Cancer and the microenvironment: myeloma-osteoclast interactions as a model. Yaccoby, S., Wezeman, M.J., Henderson, A., Cottler-Fox, M., Yi, Q., Barlogie, B., Epstein, J. Cancer Res. (2004)
- Antimyeloma efficacy of thalidomide in the SCID-hu model. Yaccoby, S., Johnson, C.L., Mahaffey, S.C., Wezeman, M.J., Barlogie, B., Epstein, J. Blood (2002)